Additionally, it was found that SGLT2 inhibitors have a neuroprotective impact by reducing antioxidants, anti-inflammatories, and antiapoptotic processes, which reduce stroke risk variables such as glucose levels, insulin resistance, triglycerides, and fat mass in the body [165]. This evidence concerns the gene SLC5A2 and Stroke.